Browse by UCL people
Group by: Type | Date
Jump to: Article
Number of items: 57.
Article
Ahmed, Mahbubl;
Collins, Shane;
Bacon, Andrew;
Franks, Joanna;
Lobo, Cheryl;
Paley, Lizz;
Strauss, Sandra;
(2021)
08. Incidence and outcome of breast sarcomas in NHS England (2013-2018): An analysis from Public Health England (PHE) National Cancer Registration and Analysis Service (NCRAS).
European Journal of Surgical Oncology
, 47
(5)
e288-e288.
10.1016/j.ejso.2021.03.204.
|
|
Anderton, J;
Moroz, V;
Marec-Bérard, P;
Gaspar, N;
Laurence, V;
Martín-Broto, J;
Sastre, A;
... Brennan, B; + view all
(2020)
International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours - EURO EWING 2012 Protocol.
Trials
, 21
(1)
, Article 96. 10.1186/s13063-019-4026-8.
|
 |
|
Beird, H;
Bielack, Stefan;
Flanagan, Adrienne;
Gill, B;
Heymann, Dominique;
Janeway, Katherine;
Livingston, JA;
... Gorlick, Richard; + view all
(2022)
Osteosarcoma.
Nature Reviews Disease Primers
, 8
, Article 77. 10.1038/s41572-022-00409-y.
|
|
Brennan, B;
Kirton, L;
Marec-Bérard, P;
Gaspar, N;
Laurence, V;
Martín-Broto, J;
Sastre, A;
... Wheatley, K; + view all
(2022)
Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial.
The Lancet
, 400
(10362)
pp. 1513-1521.
10.1016/S0140-6736(22)01790-1.
|
|
Campbell, J;
Ryan, CJ;
Brough, R;
Bajrami, I;
Pemberton, HN;
Chong, IY;
Costa-Cabral, S;
... Lord, CJ; + view all
(2016)
Large-Scale Profiling of Kinase Dependencies in Cancer Cell Lines.
Cell Reports
, 14
(10)
pp. 2490-2501.
10.1016/j.celrep.2016.02.023.
|
|
Carter, TJ;
Milic, M;
McDerra, J;
McTiernan, A;
Ahmed, M;
Karavasilis, V;
Michelagnoli, M;
... Strauss, SJ; + view all
(2020)
Continuous 14 Day Infusional Ifosfamide for Management of Soft-Tissue and Bone Sarcoma: A Single Centre Retrospective Cohort Analysis.
Cancers
, 12
(11)
, Article 3408. 10.3390/cancers12113408.
|
|
|
Casali, PG;
Blay, JY;
Abecassis, N;
Bajpai, J;
Bauer, S;
Biagini, R;
Bielack, S;
... Stacchiotti, S; + view all
(2022)
Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Annals of Oncology
, 33
(1)
pp. 20-33.
10.1016/j.annonc.2021.09.005.
|
|
Casali, PG;
Bielack, S;
Abecassis, N;
Aro, HT;
Bauer, S;
Biagini, R;
Bonvalot, S;
... Blay, JY; + view all
(2018)
Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Annals of Oncology
, 29
(4)
pp. 79-95.
10.1093/annonc/mdy310.
|
|
|
Chugh, R;
Ballman, KV;
Helman, LJ;
Patel, S;
Whelan, JS;
Widemann, B;
Lu, Y;
... Strauss, SJ; + view all
(2020)
SARC025 arms 1 and 2: A phase 1 study of the poly(ADP‐ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma.
Cancer
10.1002/cncr.33349.
|
|
|
Cottone, Lucia;
Ligammari, Lorena;
Lee, Hang-Mao;
Knowles, Helen J;
Henderson, Stephen;
Bianco, Sara;
Davies, Christopher;
... Flanagan, Adrienne M; + view all
(2022)
Aberrant paracrine signalling for bone remodelling underlies the mutant histone-driven giant cell tumour of bone.
Cell Death & Differentiation
, 29
pp. 2459-2471.
10.1038/s41418-022-01031-x.
|
|
D'Angelo, SP;
Araujo, DM;
Abdul Razak, AR;
Agulnik, M;
Attia, S;
Blay, JY;
Carrasco Garcia, I;
... Van Tine, BA; + view all
(2024)
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.
The Lancet
, 403
(10435)
pp. 1460-1471.
10.1016/S0140-6736(24)00319-2.
|
|
|
Fernanda Amary, M;
Ye, H;
Berisha, F;
Khatri, B;
Forbes, G;
Lehovsky, K;
Frezza, AM;
... Flanagan, AM; + view all
(2014)
Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo-adjuvant chemotherapy.
Cancer Med
, 3
(4)
pp. 980-987.
10.1002/cam4.268.
|
 |
|
Frezza, AM;
Beale, T;
Bomanji, J;
Jay, A;
Kalavrezos, N;
Dileo, P;
Whelan, J;
(2014)
Is [F-18]-fluorodeoxy-D-glucose positron emission tomography of value in the management of patients with craniofacial bone sarcomas undergoing neo-adjuvant treatment?
BMC Cancer
, 14
, Article 23. 10.1186/1471-2407-14-23.
|
|
|
Gaspar, N;
Campbell-Hewson, Q;
Gallego Melcon, S;
Locatelli, F;
Venkatramani, R;
Hecker-Nolting, S;
Gambart, M;
... Casanova, M; + view all
(2021)
Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050).
ESMO Open
, 6
(5)
, Article 100250. 10.1016/j.esmoop.2021.100250.
|
|
|
Gaspar, N;
Venkatramani, R;
Hecker-Nolting, S;
Melcon, SG;
Locatelli, F;
Bautista, F;
Longhi, A;
... Campbell-Hewson, Q; + view all
(2021)
Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study.
Lancet Oncology
, 22
(9)
pp. 1312-1321.
10.1016/S1470-2045(21)00387-9.
|
|
Goncalves, T;
Zoumpoulidou, G;
Alvarez-Mendoza, C;
Mancusi, C;
Collopy, LC;
Strauss, SJ;
Mittnacht, S;
(2020)
Selective Elimination of Osteosarcoma Cell Lines with Short Telomeres by Ataxia Telangiectasia and Rad3-Related Inhibitors.
ACS Pharmacology & Translational Science
, 3
(6)
pp. 1253-1264.
10.1021/acsptsci.0c00125.
|
|
Green, Darrell;
van Ewijk, Roelof;
Tirtei, Elisa;
Andreou, Dimosthenis;
Baecklund, Fredrik;
Baumhoer, Daniel;
Bielack, Stefan S;
... Nathrath, Michaela; + view all
(2024)
Biological Sample Collection to Advance Research and Treatment: A Fight Osteosarcoma Through European Research and Euro Ewing Consortium Statement.
Clinical Cancer Research
, 30
(16)
pp. 3395-3406.
10.1158/1078-0432.CCR-24-0101.
|
|
|
Gronchi, A;
Miah, AB;
DeiTos, AP;
Abecassis, N;
Bajpai, J;
Bauer, S;
Biagini, R;
... Stacchiotti, S; + view all
(2021)
Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Annals of Oncology
, 32
(11)
pp. 1348-1365.
10.1016/j.annonc.2021.07.006.
|
|
Holme, H;
Gulati, A;
Brough, R;
Fleuren, EDG;
Bajrami, I;
Campbell, J;
Chong, IY;
... Lord, CJ; + view all
(2018)
Chemosensitivity profiling of osteosarcoma tumour cell lines identifies a model of BRCAness.
Scientific Reports
, 8
, Article 10614. 10.1038/s41598-018-29043-z.
|
|
|
Ingley, KM;
Hughes, D;
Hubank, M;
Lindsay, D;
Plumb, A;
Cox, R;
Chesler, L;
(2021)
Durable response to serial tyrosine kinase inhibitors (TKIs) in an adolescent with metastatic TFG-ROS1 fusion positive Inflammatory Myofibroblastic Tumor (IMT).
Lung Cancer
, 158
pp. 151-155.
10.1016/j.lungcan.2021.05.024.
|
|
Ingley, KM;
Maleddu, A;
Le Grange, F;
Gerrand, C;
Bleyer, A;
Yasmin, E;
Whelan, J;
(2022)
Current approaches to management of bone sarcoma in adolescent and young adult patients.
Pediatric Blood & Cancer
, 69
(2)
, Article e29442. 10.1002/pbc.29442.
|
|
Ingley, KM;
Wan, S;
Vöö, S;
Windsor, R;
Michelagnoli, M;
Saifuddin, A;
Strauss, SJ;
(2021)
Is It Time to Call Time on Bone Marrow Biopsy for Staging Ewing Sarcoma (ES)?
Cancers
, 13
(13)
, Article 3261. 10.3390/cancers13133261.
|
|
|
Lidington, EK;
Smrke, A;
Ingley, KM;
Strauss, SJ;
Husson, O;
Younger, E;
(2020)
Cancer care and well-being in adolescents and young adults during the coronavirus disease 2019 pandemic: A UK sarcoma perspective.
Cancer
, 126
(24)
pp. 5359-5360.
10.1002/cncr.33215.
|
|
M, Ahmed;
S, Collins;
J, Franks;
C, Lobo;
A, Bacon;
L, Paley;
SJ, Strauss;
(2022)
Incidence and Outcome of Breast Sarcomas in England (2013–2018): An analysis from the National Cancer Registration and Analysis Service.
European Journal of Cancer
, 174
pp. 48-56.
10.1016/j.ejca.2022.06.036.
|
|
Marina, NM;
Smeland, S;
Bielack, SS;
Bernstein, M;
Jovic, G;
Krailo, MD;
Hook, JM;
... Whelan, JS; + view all
(2016)
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.
The Lancet Oncology
, 17
(10)
pp. 1396-1408.
10.1016/S1470-2045(16)30214-5.
|
|
|
Mendoza-Naranjo, A;
El-Naggar, A;
Wai, DH;
Mistry, P;
Lazic, N;
Ayala, FR;
da Cunha, IW;
... Sorensen, PH; + view all
(2013)
ERBB4 confers metastatic capacity in Ewing sarcoma.
EMBO Mol Med
, 5
(7)
1019 - 1034.
10.1002/emmm.201202343.
|
|
|
Pearson, AD;
Gaspar, N;
Janeway, K;
Campbell-Hewson, Q;
Lawlor, ER;
Copland, C;
Karres, D;
... Vassal, G; + view all
(2022)
Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
European Journal of Cancer
, 173
pp. 71-90.
10.1016/j.ejca.2022.06.008.
|
|
Peneder, P;
Stutz, AM;
Surdez, D;
Krumbholz, M;
Semper, S;
Chicard, M;
Sheffield, NC;
... Tomazou, EM; + view all
(2021)
Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden.
Nature Communications
, 12
(1)
, Article 3230. 10.1038/s41467-021-23445-w.
|
|
|
Prendergast, SC;
Strobl, A-C;
Cross, W;
Pillay, N;
Strauss, SJ;
Ye, H;
Lindsay, D;
... Amary, F; + view all
(2020)
Sarcoma and the 100,000 Genomes Project: our experience and changes to practice.
The Journal of Pathology: Clinical Research
10.1002/cjp2.174.
(In press).
|
|
|
Rothermundt, C;
Seddon, BM;
Dileo, P;
Strauss, SJ;
Coleman, J;
Briggs, TW;
Haile, SR;
(2016)
Follow-up practices for high-grade extremity Osteosarcoma.
BMC Cancer
, 16
, Article 301. 10.1186/s12885-016-2333-y.
|
|
|
Rothermundt, C;
Whelan, JS;
Dileo, P;
Strauss, SJ;
Coleman, J;
Briggs, TW;
Haile, SR;
(2014)
What is the role of routine follow-up for localised limb soft tissue sarcomas? A retrospective analysis of 174 patients.
British Journal of Cancer
, 110
(10)
pp. 2420-2426.
10.1038/bjc.2014.200.
|
|
|
Saifuddin, A;
Baig, MS;
Dalal, P;
Strauss, SJ;
(2021)
The diagnosis of pulmonary metastases on chest computed tomography in primary bone sarcoma and musculoskeletal soft tissue sarcoma.
British Journal of Radiology
, 94
(1123)
, Article 20210088. 10.1259/bjr.20210088.
|
|
Scheipl, S;
Barnard, M;
Cottone, L;
Jorgensen, M;
Drewry, DH;
Zuercher, WJ;
Turlais, F;
... Flanagan, AM; + view all
(2016)
EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen.
J Pathol
, 239
(3)
pp. 320-334.
10.1002/path.4729.
|
|
|
Schöffski, P;
Kubickova, M;
Wozniak, A;
Blay, JY;
Strauss, SJ;
Stacchiotti, S;
Switaj, T;
... Kasper, B; + view all
(2021)
Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE.
European Journal of Cancer
, 156
pp. 12-23.
10.1016/j.ejca.2021.07.016.
|
|
|
Schöffski, P;
Sufliarsky, J;
Gelderblom, H;
Blay, J-Y;
Strauss, SJ;
Stacchiotti, S;
Rutkowski, P;
... Wozniak, A; + view all
(2018)
Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial.
Lancet Respir Med
, 6
(6)
pp. 431-441.
10.1016/S2213-2600(18)30116-4.
|
|
|
Schöffski, P;
Wozniak, A;
Casali, PG;
Rutkowski, P;
Blay, J-Y;
Lindner, LH;
Strauss, SJ;
... Bauer, S; + view all
(2017)
Activity and safety of crizotinib in patients with advanced clear cell sarcoma with MET alterations. European Organization for Research and Treatment of Cancer phase 2 trial 90101 "CREATE".
Annals of Oncology
, 28
(12)
pp. 3000-3008.
10.1093/annonc/mdx527.
|
|
Schöffski, P;
Wozniak, A;
Kasper, B;
Aamdal, S;
Leahy, MG;
Rutkowski, P;
Bauer, S;
... Stacchiotti, S; + view all
(2018)
Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 'CREATE'.
Annals of Oncology
, 29
(3)
pp. 758-765.
10.1093/annonc/mdx774.
|
|
Schöffski, P;
Wozniak, A;
Leahy, MG;
Aamdal, S;
Rutkowski, P;
Bauer, S;
Richter, S;
... Strauss, SJ; + view all
(2018)
The tyrosine kinase inhibitor crizotinib does not have clinically meaningful activity in heavily pre-treated patients with advanced alveolar rhabdomyosarcoma with FOXO rearrangement: European Organisation for Research and Treatment of Cancer phase 2 trial 90101 'CREATE'.
European Journal of Cancer
, 94
pp. 156-167.
10.1016/j.ejca.2018.02.011.
|
|
Seddon, B;
Strauss, SJ;
Whelan, J;
Leahy, M;
Woll, PJ;
Cowie, F;
Rothermundt, C;
... Beare, S; + view all
(2017)
Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial.
The Lancet Oncology
, 18
(10)
pp. 1397-1410.
10.1016/S1470-2045(17)30622-8.
|
|
Smeland, S;
Ingleby, F;
Many other authors, TPUTP;
Whelan, J;
Sydes, MR;
(2019)
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 cohort.
European Journal of Cancer
, 109
pp. 36-50.
10.1016/j.ejca.2018.11.027.
|
|
|
Stacchiotti, S;
Maria Frezza, A;
Demetri, GD;
Blay, JY;
Bajpai, J;
Baldi, GG;
Baldini, EH;
... Wagner, AJ; + view all
(2022)
Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments.
Cancer Treatment Reviews
, 110
, Article 102455. 10.1016/j.ctrv.2022.102455.
|
|
Stacchiotti, S;
Miah, AB;
Frezza, AM;
Messiou, C;
Morosi, C;
Caraceni, A;
Antonescu, CR;
... Gronchi, A; + view all
(2021)
Enithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts.
ESMO OPEN
, 6
(3)
, Article 100170. 10.1016/j.esmoop.2021.100170.
|
|
|
Steele, CD;
Tarabichi, M;
Oukrif, D;
Webster, AP;
Ye, H;
Fittall, M;
Lombard, P;
... Pillay, N; + view all
(2019)
Undifferentiated Sarcomas Develop through Distinct Evolutionary Pathways.
Cancer Cell
, 35
(3)
441-456.e8.
10.1016/j.ccell.2019.02.002.
|
|
|
Strauss, Sandra;
(2023)
Incidence and survival of soft tissue sarcoma in England between 2013-2017, an analysis from the National Cancer Registration and Analysis Service.
International Journal of Cancer
, 152
(9)
pp. 1789-1803.
10.1002/ijc.34409.
|
|
Strauss, Sandra J;
Berlanga, Pablo;
McCabe, Martin G;
(2024)
Emerging therapies in Ewing sarcoma.
Current Opinion in Oncology
, 36
(4)
pp. 297-304.
10.1097/CCO.0000000000001048.
|
|
Strauss, SJ;
Frezza, AM;
Abecassis, N;
Bajpai, J;
Bauer, S;
Biagini, R;
Bielack, S;
... Stacchiotti, S; + view all
(2021)
Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up.
Annals of Oncology
, 32
(12)
pp. 1520-1536.
10.1016/j.annonc.2021.08.1995.
|
|
Strauss, SJ;
Anninga, J;
Baglio, R;
Baumhoer, D;
Behjati, S;
Bielack, S;
Boye, K;
... Whelan, J; + view all
(2018)
Report from the 4th European Bone Sarcoma Networking meeting: focus on osteosarcoma.
Clinical Sarcoma Research
, 8
, Article 17. 10.1186/s13569-018-0103-0.
|
|
|
Strauss, SJ;
Whelan, JS;
(2018)
Current questions in bone sarcomas.
Current Opinion in Oncology
, 30
(4)
pp. 252-259.
10.1097/CCO.0000000000000456.
|
|
Tigelaar, Leonie G;
Blom, Kiki J;
Bekkering, Willem P;
Bramer, Jos AM;
Schreuder, Hendrik WB;
Furtado, Sherron;
Gerrand, Craig H;
... Haveman, Lianne M; + view all
(2025)
The landscape of Functional Outcome Measures Used in Patients with Bone Sarcoma of the Lower Extremity or Pelvis: A Systematic Review.
Journal of Surgical Oncology
, 131
(3)
pp. 514-526.
10.1002/jso.27921.
|
|
Tirotta, Fabio;
Bacon, Andrew;
Collins, Shane;
Desai, Anant;
Liu, Hanhua;
Paley, Lizz;
Strauss, Dirk;
(2023)
Primary retroperitoneal sarcoma: A comparison of survival outcomes in specialist and non-specialist sarcoma centres.
European Journal of Cancer
, 188
pp. 20-28.
10.1016/j.ejca.2023.04.004.
|
|
van Ewijk, R;
Herold, N;
Baecklund, F;
Baumhoer, D;
Boye, K;
Gaspar, N;
Harrabi, SB;
... Kager, L; + view all
(2023)
European standard clinical practice recommendations for children and adolescents with primary and recurrent osteosarcoma.
EJC Paediatric Oncology
, 2
, Article 100029. 10.1016/j.ejcped.2023.100029.
|
|
|
van Ewijk, Roelof;
Cleirec, Morgane;
Herold, Nikolas;
le Deley, Marie-Cécile;
van Eijkelenburg, Natasha;
Boudou-Rouquette, Pascaline;
Risbourg, Séverine;
... FOSTER Consortium, .; + view all
(2023)
A systematic review of recent phase-II trials in refractory or recurrent osteosarcoma: Can we inform future trial design?
Cancer Treatment Reviews
, 120
, Article 102625. 10.1016/j.ctrv.2023.102625.
(In press).
|
|
|
Windsor, Rachael;
Hamilton, Anthony;
McTiernan, Anne;
Dileo, Palma;
Michelagnoli, Maria;
Seddon, Beatrice;
Strauss, Sandra J;
(2022)
Survival after high-dose chemotherapy for refractory and recurrent Ewing sarcoma.
European Journal of Cancer
, 170
pp. 131-139.
10.1016/j.ejca.2022.04.007.
|
|
Woll, Penella J;
Gaunt, Piers;
Gaskell, Charlotte;
Young, Robin;
Benson, Charlotte;
Judson, Ian R;
Seddon, Beatrice M;
... Billingham, Lucinda; + view all
(2023)
Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata.
British Journal of Cancer (BJC)
10.1038/s41416-023-02416-6.
(In press).
|
|
Wood, Georgina E;
Graves, Laurie A;
Rubin, Elyssa M;
Reed, Damon R;
Riedel, Richard F;
Strauss, Sandra J;
(2023)
Bad to the Bone: Emerging Approaches to Aggressive Bone Sarcomas.
American Society of Clinical Oncology Educational Book
, 43
(43)
, Article e390306. 10.1200/EDBK_390306.
|
|
Younger, E;
Smrke, A;
Lidington, E;
Farag, S;
Ingley, K;
Chopra, N;
Maleddu, A;
... Jones, RL; + view all
(2020)
Health-Related Quality of Life and Experiences of Sarcoma Patients during the COVID-19 Pandemic.
Cancers
, 12
(8)
, Article 2288. 10.3390/cancers12082288.
|
|
|
Zoumpoulidou, G;
Alvarez-Mendoza, C;
Mancusi, C;
Ahmed, R-M;
Denman, M;
Steele, CD;
Tarabichi, M;
... Mittnacht, S; + view all
(2021)
Therapeutic vulnerability to PARP1,2 inhibition in RB1-mutant osteosarcoma.
Nature Communications
, 12
(1)
, Article 7064. 10.1038/s41467-021-27291-8.
|
|
